Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluoropropane-albumin microspheres for hysterosalpingo-contrast sonography
CTR20220578Phase 3Completed
- Sponsor
- Lizhuo Pharmaceutical (Xiamen) Co., Ltd.
- Start
- Mar 2022
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perfluoropropane-albumin microspheres, sponsored by Lizhuo Pharmaceutical (Xiamen) Co., Ltd.. Started Mar 2022; status: completed.
02
Drugs
perfluoropropane-albumin microspheres
Beyond the preview
Go deeper on CTR20220578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220578.